A tyrosine703serine polymorphism of CD109 defines the Gov platelet alloantigens.
about
Human platelet antigen-specific alloantibodies implicated in 1162 cases of neonatal alloimmune thrombocytopeniaRapid and reliable genotyping of human platelet antigen (HPA)-1, -2, -3, -4, and -5 a/b and Gov a/b by melting curve analysis.Human platelet alloantigens (HPAs): PCR-SSP genotyping of a UK population for 15 HPA alleles.High-throughput genotyping of human platelet antigens using the 5'-nuclease assay and minor groove binder probe technology.Relevance of the HPA-15 (Gov) polymorphism on CD109 in alloimmune thrombocytopenic syndromes.Frequencies of maternal platelet alloantibodies and autoantibodies in suspected fetal/neonatal alloimmune thrombocytopenia, with emphasis on human platelet antigen-15 alloimmunization.Neonatal alloimmune thrombocytopenia caused by human leucocyte antigen-B27 antibody.New low-frequency platelet glycoprotein polymorphisms associated with neonatal alloimmune thrombocytopenia.A new Ser472Asn (Cab2(a+)) polymorphism localized within the αIIb "thigh" domain is involved in neonatal thrombocytopenia.Molecular insight into human platelet antigens: structural and evolutionary conservation analyses offer new perspective to immunogenic disordersThe relevance of HPA-15 antigen expression for anti-HPA-15 antibody detection.Neonatal alloimmune thrombocytopenia: pathogenesis, diagnosis and management.The role of alloantibodies against human platelet antigen-15 in multiply platelet transfused patients.Frequency of human platelet antigens (HPA)-1, -2, -5 and -15 in Brazilian blood donors and establishment of a panel of HPA-typed donors.Current perspectives on fetal and neonatal alloimmune thrombocytopenia - increasing clinical concerns and new treatment opportunities.CD109 expression in squamous cell carcinoma of the uterine cervix.Genotyping for platelet-specific antigens: techniques for the detection of single nucleotide polymorphisms.Human platelet antigen genotyping and expression of CD109 (human platelet antigen 15) mRNA in various human cell types.Investigation of prognostic significance of CD109 expression in women with vulvar squamous cell carcinoma.HPA polymorphism in sub-Saharan African populations: Beninese, Cameroonians, Congolese, and Pygmies.High-level expression of CD109 is frequently detected in lung squamous cell carcinomas.Expression of recombinant ITGA2 and CD109 for the detection of human platelet antigen (HPA)-5 and -15 alloantibodies.Human platelet antigen genotyping by using sequence-specific primers and the particle gel agglutination assay.Gene frequencies of the HPA-15 (Gov) platelet alloantigen system in Brazilians.High-throughput simultaneous genotyping of human platelet antigen-1 to -16 by using suspension array.Fetal/neonatal alloimmune thrombocytopenia due to anti-CD36 antibodies: antibody evaluations by CD36-transfected cell lines.The impact of universal leukodepletion of the blood supply on hemovigilance reports of posttransfusion purpura and transfusion-associated graft-versus-host disease.Genetic stratification of pathogen-response-related and other variants within a homogeneous Caucasian Irish population.Report on the Eleventh International Society of Blood Transfusion Platelet Genotyping and Serology Workshop.Human platelet-specific antigens frequencies in the Argentinean population.Platelet immunobiology: platelets as prey and predator
P2860
Q28273018-285EB1E0-5A1E-4461-ABD0-886D692B828DQ33347179-DA10C51B-AE18-45C8-88D0-FEACA79A63C1Q33358175-51FC107B-C8F6-4D28-B0F3-60C95BAFAFFEQ33362522-30824558-8E9F-4E49-B99D-2892DDFDFB36Q33365275-B41626E2-6F37-4EB8-B863-8D598A2E1B5BQ33366648-9BE18B3B-5B5B-4D0E-80E0-B29EB8A18AF4Q33370897-1749CC4E-C630-4D63-8FDE-1BA9D7FAB294Q33386590-8EB01DD1-7A6A-4A19-B936-44FCA8965EBAQ33391496-DC6AC292-3243-4E51-A43E-E9B3EDCBE266Q33391693-53C38038-E25D-4D43-8F13-16FCC5F5D394Q33396238-363BF624-F40A-4BF8-9E86-C33ADBE735D6Q33405694-029BE67F-E7E9-4132-BF0F-EC62A4E91C51Q33411070-EE97DCE4-A09B-48E0-B2BE-AFCFC8B762FCQ33423285-76FDF02D-A141-4DC9-8781-8A0329D22DD3Q33441520-B8645AC3-571E-4D71-B7C1-4CA8F14331A7Q34410942-2F303A9C-17B3-428B-A477-6E54797ECB80Q34722819-00C99802-563A-4C22-B225-2E1492D14D9DQ36641017-30E4570D-DF38-4A36-99EB-FFF5AF7DF8CCQ36925909-824DE950-9254-4E67-8C32-7CB53EDBB4C6Q39042289-1C2EA382-1530-4B7B-B6A1-DA2CA7D94C59Q42519941-4ABD1D77-A879-4729-AA94-2AD9910EE1EAQ45454471-2454CFC8-40B3-4612-9C4A-067B137F682CQ46475682-22C5AF31-3B31-4D53-BB83-A4A084481911Q46548840-3AD8E380-3316-4D12-8262-E5650E2540D4Q46609352-A943CC93-3A5F-4847-9584-9578095CA101Q50067634-EC0ED51F-576D-42E2-98DA-79E0239D4738Q50686453-484868FD-9CFA-453C-883F-3AAC6B841B2AQ50774063-DDEC80B5-9FA5-4C8E-9C77-0975DC29EC62Q53298578-6081F69C-CB07-441D-9920-E718765E76BFQ54537929-0015BEA1-EFDA-4C70-A3E0-13B0D8C02F04Q57676574-A37D70C5-4CCF-41DB-8EDC-0C197529D25A
P2860
A tyrosine703serine polymorphism of CD109 defines the Gov platelet alloantigens.
description
2002 nî lūn-bûn
@nan
2002 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի մարտին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
A tyrosine703serine polymorphism of CD109 defines the Gov platelet alloantigens.
@ast
A tyrosine703serine polymorphism of CD109 defines the Gov platelet alloantigens.
@en
type
label
A tyrosine703serine polymorphism of CD109 defines the Gov platelet alloantigens.
@ast
A tyrosine703serine polymorphism of CD109 defines the Gov platelet alloantigens.
@en
prefLabel
A tyrosine703serine polymorphism of CD109 defines the Gov platelet alloantigens.
@ast
A tyrosine703serine polymorphism of CD109 defines the Gov platelet alloantigens.
@en
P2093
P356
P1433
P1476
A tyrosine703serine polymorphism of CD109 defines the Gov platelet alloantigens.
@en
P2093
Andre C Schuh
D Robert Sutherland
Joseph Y A Prosper
Kate Campbell
Martin Lin
Nicholas J Harmer
Nick A Watkins
Paul Metcalfe
Quang Nguyen
Wendy Horsfall
P304
P356
10.1182/BLOOD.V99.5.1692
P407
P577
2002-03-01T00:00:00Z